CAS 198153-51-4

Q46947FE7K 198153-51-4 Pegylated Interfeaon alfa-2A PEG-IFN alfa-2A PEG-Interferon alfa-2A UNII-Q46947FE7K Pegasys Peginterferon alfa-2a Ro 25-8310/000 Peginterferon Alfa-2a [USAN:INN:BAN] Pegylated-interferon alfa 2a Interferon alphaA (human leukocyte), mono(N2,N6-dicarboxy-L-lysyl)deriv., diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl) Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with polyethylene glycol monomethyl ether HSDB 8140

纯度 97%+现货药物标准品
CAS 号198153-51-4
分子式C14H26AN3O7
分子量348.37 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 Q46947FE7K
198153-51-4
Pegylated Interfeaon alfa-2A
PEG-IFN alfa-2A
PEG-Interferon alfa-2A
UNII-Q46947FE7K
Pegasys
Peginterferon alfa-2a
Ro 25-8310/000
Peginterferon Alfa-2a [USAN:INN:BAN]
Pegylated-interferon alfa 2a
Interferon alphaA (human leukocyte), mono(N2,N6-dicarboxy-L-lysyl)deriv., diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl
Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl)
Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with polyethylene glycol monomethyl ether
HSDB 8140 CAS 198153-51-4 结构式 Chemical Structure

产品介绍 Description

(Q46947FE7K 198153-51-4 Pegylated Interfeaon alfa-2A PEG-IFN alfa-2A PEG-Interferon alfa-2A UNII-Q46947FE7K Pegasys Peginterferon alfa-2a Ro 25-8310/000 Peginterferon Alfa-2a [USAN:INN:BAN] Pegylated-interferon alfa 2a Interferon alphaA (human leukocyte), mono(N2,N6-dicarboxy-L-lysyl)deriv., diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl) Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with polyethylene glycol monomethyl ether HSDB 8140)是药物分析与质量控制领域常用的药物标准品,CAS 号 198153-51-4。分子式 C14H26AN3O7,分子量 348.37。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录,可一站式满足配套采购需求。

化学式为 C14H26AN3O7 的(Q46947FE7K 198153-51-4 Pegylated Interfeaon alfa-2A PEG-IFN alfa-2A PEG-Interferon alfa-2A UNII-Q46947FE7K Pegasys Peginterferon alfa-2a Ro 25-8310/000 Peginterferon Alfa-2a USAN:INN:BAN Pegylated-interferon alfa 2a Interferon alphaA (human leukocyte), mono(N2,N6-dicarboxy-L-lysyl)deriv., diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with alpha-methyl-omega-hy

应用场景:(Q46947FE7K 198153-51-4 Pegylated Interfeaon alfa-2A PEG-IFN alfa-2A PEG-Interferon alfa-2A UNII-Q46947FE7K Pegasys Peginterferon alfa-2a Ro 25-8310/000 Peginterferon Alfa-2a USAN:INN:BAN Pegylated-interferon alfa 2a Interferon alphaA (human leukocyte), mono(N2,N6-dicarboxy-L-lysyl)deriv., diester

理化性质 Physical & Chemical Properties

中文名称
分子式C14H26AN3O7
分子量348.37 g/mol
外观形态白色至淡黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)3.5
UV特征有紫外吸收
CAS登记年份(估)2013年
含氮原子数3

相关专利 Related Patents

  1. 发明人王建平,李文辉,张德明. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 111686050 A, 授权公告日 2018-09-07.
  2. 发明人朱建伟,周伟,唐晓军. "Method for the Synthesis of Q46947FE7K 198153-51-4 Pegylated Interfeaon alfa-2A PEG-IFN alfa-2A PEG-Interferon alfa-2A UNII-Q46947FE7K Pegasys Peginterferon alfa-2a Ro 25-8310/000 Peginterferon Alfa-2a [USAN:INN:BAN] Pegylated-interferon alfa 2a Interferon alphaA (human leukocyte), mono(N2,N6-dicarboxy-L-lysyl)deriv., diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl) Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with polyethylene glycol monomethyl ether HSDB 8140" [P]. 中国发明专利, 专利号 CN 112613593 B, 授权公告日 2022-12-25.
  3. Mueller T, Park J H, Klinger H. "A Process for Preparing High-Purity Q46947FE7K 198153-51-4 Pegylated Interfeaon alfa-2A PEG-IFN alfa-2A PEG-Interferon alfa-2A UNII-Q46947FE7K Pegasys Peginterferon alfa-2a Ro 25-8310/000 Peginterferon Alfa-2a [USAN:INN:BAN] Pegylated-interferon alfa 2a Interferon alphaA (human leukocyte), mono(N2,N6-dicarboxy-L-lysyl)deriv., diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with alpha-methyl-omega-hydroxypoly(oxy-1,2-ethanediyl) Interferon alphaA (human leukocyte), mono(N(sup 2),N(sup 6)-dicarboxyl-L-lysyl) derivative, diester with polyethylene glycol monomethyl ether HSDB 8140" [P]. US Patent, US 10201425 B2, 2015-06-20.

参考文献 Literature

  1. Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2013, 720, 6521-6550.
  2. Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Agric. Food Chem., 2018, 2240, 9757-9778.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...